遗传性甲状旁腺机能减退
Genetic hypoparathyroidism
近两年的全球研究 10L2
2024/08 起在 Europe PMC 检索所得,按发表时间倒序显示最近 10 篇。标题未译成中文——自动翻译需要接入 LLM 服务,尚未引入。
- 2026-03综述开放获取First Reported Use of Recombinant Parathyroid Hormone in Kenny-Caffey Syndrome Type 2: A Case Report and Literature Review
- 2026-01综述开放获取Endocrine Disorders of Calcium Signaling in Children: Neuroendocrine Crosstalk and Clinical Implications
- 2025-12综述Repurposing osteoporosis medications for other diseases: a narrative review by the European Calcified Tissue Society (ECTS)
- 2025-09Genetic screening in a large Chinese cohort of adult-onset non-surgical hypoparathyroidism
- 2025-07开放获取A calcium-sensing receptor allelic series and underdiagnosis of genetically driven hypocalcemia
- 2025-04综述开放获取Generation of parathyroid glands from pluripotent stem cells
- 2025-01开放获取SAT-746 Gain-of-Function CASR variants Identified as a Major Genetic Contributor of Non-Surgical Hypoparathyroidism: Findings from Over 300 Participants in a Sponsored Genetic Testing Program
- 2024-11Classification and epidemiologic analysis of 86 diseases in <i>China's Second List of Rare Diseases</i>
- 2024-10开放获取8669 Characteristics Of Adults with Autosomal Dominant Hypocalcemia Type 1 (ADH1) Enrolled In The CLARIFY Disease Monitoring Study
- 2024-10开放获取9295 Characteristics Of Adults with Autosomal Dominant Hypocalcemia Type 1 (ADH1) Enrolled In The CLARIFY Disease Monitoring Study
中国境外的在招试验 13L2
这些试验在中国没有研究中心,通常无法直接报名——入组一般要求在当地居住并接受随访。列在这里是因为它另有用处:看清楚全世界正在试哪些药、做到了哪一期、由谁在做。把药名和 NCT 编号记下来去问主治医生,或据此进一步查该药是否已在境外获批、是否有拓展性用药(expanded access)通道。
美国5荷兰2突尼斯1意大利1加拿大1瑞士1法国1以色列1
共 13 项。
- 招募中NCT07083557Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)美国
- 招募中NCT07284641Hematopoietic Stem Cell Transplantation (HSCT) for Common Variable Immunodeficiency (CVID) and Other Autoimmune Manifestations of Primary Immune Regulatory Disorders (PIRD)美国
- 招募中NCT07493096Intensive Multimodal Neurorehabilitation Targeting Neuroplasticity in Pediatric Neurodevelopmental and Chromosomal Disorders美国
- 招募中NCT07643896The ADVANCE (Assay Development and Validation for Pre-Natal and Obstetric Conditions) Study is the Largest U.S.-Based Prospective Study Demonstrating a Circulating Fetal Cell (CFC) Based Approach to Non-invasive Fetal Risk Assessment美国
- 尚未开始招募NCT06445036Tunisian Clinical Registry on Hypoparathyroidism and Pseudo-hypoparathyroidism突尼斯
- 招募中NCT06645899Institution of an Italian Multicenter Database of Patients Affected by Hypoparathyroidism or Pseudohypoparathyroidism意大利
- 招募中NCT06081348Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders加拿大
- 招募中NCT05664412Using Transcranial Alternating Current Stimulation to Improve Executive Function in 22q11.2 Deletion Syndrome瑞士
- 招募中NCT05924347Early Scoliotic Changes in Children at Increased Risk for Scoliosis Development荷兰
- 招募中NCT04639388Understanding of Psychotic Disorders in Children With 22q11.2DS法国
- 招募中NCT04463316GROWing Up With Rare GENEtic Syndromes荷兰
- 招募中NCT00556530Examining Genetic Factors That Affect the Severity of 22q11.2 Deletion Syndrome美国
- 招募中NCT00768820The Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome以色列
外部标识与链接
发现这一页有错误?告诉我 · 邮件主题会自动带上本页的 ORPHA 编号
本页数据来源
- 疾病定义、同义词、基因、表型、流行病学:Orphanet(CC BY 4.0)
- 中文病名:Orphanet 中文包,冻结于 2020-06-01
- 表型中文标签:HPO 简体中文翻译(CHPO 上游成果)